Activity and toxicity profile of eribulin mesylate in heavily pretreated metastatic breast cancer: An observational study (EVHALAVEN)

被引：1
|
作者：
Patsouris, A. [1 ]
Septans, A. L. [2 ]
Paillard, M. J. [3 ]
Pivot, X. [3 ]
Soibinet, P. [4 ]
Jovenin, N. [4 ]
Robert, M. [5 ]
Gourmelon, C. [5 ]
Korembaum, C. [6 ]
Petit, T. [6 ]
Martin-Babau, J. [7 ]
Brunot, A. [8 ]
Lefeuvre-Plesse, C. [8 ]
Adele, M. [9 ]
Bourgeois, H. [9 ]
Som, M. [10 ]
Uwer, L. [11 ]
Campone, M. [5 ]
Campion, L. [12 ]
Tredan, O. [13 ]
机构：
[1] Integrated Ctr Oncol Paul Papin, Med Oncol, Angers, France
[2] Integrated Ctr Oncol Paul Papin, Stat Unit, Angers, France
[3] CHRU Besancon, Oncol Med, Besancon, France
[4] Jean Godinot Inst, Med Oncol, Reims, France
[5] Integrated Ctr Oncol Rene Gauducheau, Med Oncol, Nantes, France
[6] Ctr Paul Strauss, Med Oncol, Strasbourg, France
[7] CHU Brest Morvan, Med Oncol, Brest, France
[8] Ctr Eugene Marquis, Med Oncol, Rennes, France
[9] Ctr Jean Bernard, Med Oncol, Le Mans, France
[10] Clin Armoricaine, Med Oncol, St Brieux, France
[11] Ctr Alexis Vautrin, Med Oncol, Nancy, France
[12] Integrated Ctr Oncol Rene Gauducheau, Stat Unit, Nantes, France
[13] Ctr Leon Berard, Med Oncol, F-69373 Lyon, France
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30815-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1865
引用
收藏
页码：S287 / S287
页数：1
相关论文
共 50 条
  • [1] Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: What next?
    Aftimos, Philippe
    Awada, Ahmad
    ADVANCES IN THERAPY, 2011, 28 (11) : 973 - 985
  • [2] Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: What next?
    Philippe Aftimos
    Ahmad Awada
    Advances in Therapy, 2011, 28 : 973 - 985
  • [3] Eribulin Mesylate in Pretreated Breast Cancer Patients: A Multicenter Retrospective Observational Study
    Gamucci, Teresa
    Michelotti, Andrea
    Pizzuti, Laura
    Mentuccia, Lucia
    Landucci, Elisabetta
    Sperduti, Isabella
    Di Lauro, Luigi
    Fabi, Alessandra
    Tonini, Giuseppe
    Sini, Valentina
    Salesi, Nello
    Ferrarini, Ilaria
    Vaccaro, Angela
    Pavese, Ida
    Veltri, Enzo
    Moscetti, Luca
    Marchetti, Paolo
    Vici, Patrizia
    JOURNAL OF CANCER, 2014, 5 (05): : 320 - 327
  • [4] Activity of eribulin mesylate in heavily pretreated breast cancer granted access via the Cancer Drugs Fund
    Ramaswami, Ramya
    O'Cathail, Sean M.
    Brindley, James H.
    Silcocks, Paul
    Mahmoud, Sarah
    Palmieri, Carlo
    FUTURE ONCOLOGY, 2014, 10 (03) : 363 - 376
  • [5] Eribulin mesylate in heavily pretreated metastatic breast cancer patients: current practice in an Italian community hospital
    Poletti, Paola
    Ghilardi, Valentina
    Livraghi, Luca
    Milesi, Laura
    Caremoli, Elena Rota
    Tondini, Carlo
    FUTURE ONCOLOGY, 2014, 10 (02) : 233 - 239
  • [6] Safety and tolerability of eribulin mesylate in patients with pretreated metastatic breast cancer
    Goodin, Susan
    Barbour, Sally
    Song, James
    Berrak, Erhan
    Cox, David
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (24) : 2150 - 2156
  • [7] Efficacy and toxicity profile of eribulin mesylate for metastatic breast cancer (MBC) patients (pts) in the routine clinic: A French observational study.
    Patsouris, Anne
    Linot, Benjamin
    Robert, Marie
    Gourmelon, Carole
    Campone, Mario
    Brunot, Angelique
    Lefeuvre-Plesse, Claudia
    Martin, Jerome
    Marquis, Adele
    Bourgeois, Hugues Pierre
    Som, Mickael
    Desclos, Herve
    Tredan, Olivier
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Eribulin: a new treatment option in metastatic breast cancer heavily pretreated?
    Goncalves, Anthony
    BULLETIN DU CANCER, 2011, 98 (05) : 455 - 455
  • [9] A phase II study of eribulin in Japanese patients with heavily pretreated metastatic breast cancer
    Aogi, K.
    Iwata, H.
    Masuda, N.
    Mukai, H.
    Yoshida, M.
    Rai, Y.
    Taguchi, K.
    Sasaki, Y.
    Takashima, S.
    ANNALS OF ONCOLOGY, 2012, 23 (06) : 1441 - 1448
  • [10] Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study
    Pedersini, Rebecca
    Vassalli, Lucia
    Claps, Melanie
    Tulla, Antonella
    Rodella, Filippo
    Grisanti, Salvatore
    Amoroso, Vito
    Roca, Elisa
    Simoncini, Edda Lucia
    Berruti, Alfredo
    ONCOLOGY, 2018, 94 : 10 - 15
12345